<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03821428</url>
  </required_header>
  <id_info>
    <org_study_id>BB 166/18</org_study_id>
    <nct_id>NCT03821428</nct_id>
  </id_info>
  <brief_title>Acupuncture for Relief of Gag Reflex</brief_title>
  <acronym>AcuGag</acronym>
  <official_title>Acupuncture for Relief of Gag Reflex in Patients Undergoing Transesophageal Echocardiography - a Randomized Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to test whether stimulation of acupuncture points CV24 and P6 is
      better than placebo acupuncture in treatment of gagging in patients undergoing elective
      transesophageal echocardiography (TEE)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing elective transesophageal echocardiography (TEE) often report discomfort
      because of active gagging reflex, which sometimes preclude the performance of TEE and
      requires additional medication. According to existing literature, needling of acupoint CV24
      effectively prevents gagging during dental procedures. We are going to use this phenomenon in
      patients scheduled to TEE in order to reduce discomfort during insertion of TEE probe and
      reduce the need for additional sedative medication. Within this investigation the patients
      will be randomly assigned to receive either verum acupuncture of CV24 and P6 acupoints or
      placebo procedure immediately before TEE examination. As outcome the incidence and intensity
      of gagging, total dose of additional sedative medication and hemodynamic parameters will be
      recorded.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2019</start_date>
  <completion_date type="Anticipated">December 20, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of gagging during probe insertion</measure>
    <time_frame>10 minutes after TEE probe insertion</time_frame>
    <description>Incidence of gagging during TEE probe insertion: yes=1; no=2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gagging score</measure>
    <time_frame>10 minutes after TEE probe insertion</time_frame>
    <description>Gagging score on Verbal Rating Scale from 0 to 10, where 0=no discomfort from TEE probe; 10=maximal discomfort during TEE probe insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue medication</measure>
    <time_frame>10 minutes after TEE probe insertion</time_frame>
    <description>Use of midazolam as rescue medication, given as a summary dose of required midazolam from minimum 1 milligram to maximum 10 milligram</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gagging During Transesophageal Echocardiography</condition>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Needling of acupoints P6 and CV24 with indwelling permanent needles, withdrawn after TEE procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Application of Placebo needles in the areas of P6 and CV24 acupoints</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Needling of P6 and CV24 points</description>
    <arm_group_label>Acupuncture</arm_group_label>
    <other_name>Verum acupuncture</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Application of placebo acupuncture needles to the areas, where the acupoints are situated</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Placebo acupuncture</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with an American Society of Anesthesiologists physical status of I to III
             scheduled for elective ambulatory transesophageal echocardiography (TEE) without
             sedation

          2. TEE time does not exceed 30 minutes

          3. Patients without previous opioid and psychotropic medication

          4. Patients aged between 30 and 65 years, able to use visual analogue scale 100 mm

          5. Patients who have given written informed consent

        Exclusion Criteria:

          1. Current psychiatric disease

          2. Local skin infection at the sites of acupuncture

          3. Aged &lt; 30 or &gt; 65 years

          4. TEE time more than 30 min

          5. Patients who consumed opioid medication at least 6 months before surgery

          6. Patients with the history of: i) psychiatric disease; ii) insulin-dependent diabetes
             mellitus; iii) radio- or chemotherapy; iv) peripheral polyneuropathy.

          7. Patients who are unable to understand the consent form or to use visual analogue scale
             100 mm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Taras Usichenko</last_name>
    <role>Study Chair</role>
    <affiliation>University Medicine of Greifswald</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Taras Usichenko, MD, PhD</last_name>
    <phone>+49 3834865893</phone>
    <email>taras@uni-greifswald.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irina Müller-Kozarez, MD</last_name>
    <phone>+49 38348680699</phone>
    <email>irina.mueller-kozarez@uni-greifswald.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medicine of Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Müller-Kozarez, MD, PhD</last_name>
      <phone>+4938348680699</phone>
      <email>irina.mueller-kozarez@uni-greifswald.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 25, 2019</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2019</study_first_posted>
  <last_update_submitted>January 30, 2019</last_update_submitted>
  <last_update_submitted_qc>January 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gagging</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

